Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Edelman Joseph
Relationship:   Former 10% Owner
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   42    
Direct Shares   630,171    

Indirect Shares

   332,164,708      
Direct Value   $1,451,351    

Indirect Value

   $2,860,681,280      
Total Shares   332,794,879      
Total Value   $2,862,132,631      


Aegerion Pharmaceuticals, Inc. $0 Nautilus Biotechnology, Inc $1,451,351 Aegerion Pharmaceuticals, Inc. $0 Nautilus Biotechnology, Inc $1,451,351
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    79   
    21    

     Stock price went up :
    50   
    11    
     Stock price went down :
    29   
    10    
   
     Gain/Loss Ratio :
   1.7   
   1.1   
     Percentage Gain/Loss :
   13.4%
 197.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Penwest Pharmaceuticals Co PPCO 10% Owner 2008-06-23 0 2008-06-23 6,387,546    Premium*  
            Synageva BioPharma Corp GEVA 10% Owner 0 2011-11-02 0    Premium*  
            Aegerion Pharmaceuticals, Inc. AEGR 10% Owner 2012-11-01 133,133 2012-11-29 2,595,293    Premium*  
            Acelrx Pharmaceuticals Inc ACRX 10% Owner 0 2017-06-19 4,533,728    Premium*  
            Amicus Therapeutics Inc FOLD 10% Owner 0 2018-10-03 20,724,424    Premium*  
            VBI Vaccines Inc VBIV 10% Owner 0 2014-07-25 2,610,356    Premium*  
            Aldeyra Therapeutics, Inc. ALDX 10% Owner 0 2024-04-05 9,275,851    Premium*  
            Aravive Inc ARAV 10% Owner 0 2017-09-22 2,099,563    Premium*  
            Kadmon Holdings, Llc KDMN 10% Owner 0 2019-11-18 14,636,334    Premium*  
            Zogenix, Inc. ZGNX 10% Owner 2017-09-29 0 2018-08-10 4,070,357    Premium*  
            Global Blood Therapeutics, Inc. GBT 10% Owner 2017-12-19 0 2017-12-19 4,889,066    Premium*  
            Corium International, Inc. CORI 10% Owner 2018-01-16 0 2018-10-12 2,724,686    Premium*  
            Albireo Pharma Inc ALBO 10% Owner 2018-01-25 0 2022-10-13 1,939,723    Premium*  
            Solid Biosciences Inc SLDB Director, 10% Owner 2018-01-30 0 2024-01-11 6,906,646    Premium*  
            La Jolla Pharmaceutical Co LJPC 10% Owner 2018-02-13 0 2019-01-08 2,253,376    Premium*  
            Motus Gi Holdings Inc MOTS 10% Owner 2018-02-16 0 2021-01-22 2,660,542    Premium*  
            Quotient Ltd QTNTQ 10% Owner 2018-05-22 0 2022-10-31 7,945,211    Premium*  
            Dova Pharmaceuticals, Inc. DOVA 10% Owner 2018-06-04 0 2019-11-12 0    Premium*  
            Meiragtx Holdings Plc MGTX 10% Owner 2018-06-08 0 2023-05-05 11,281,103    Premium*  
            Crinetics Pharmaceuticals, Inc. CRNX 10% Owner 2018-07-20 0 2022-04-18 5,321,032    Premium*  
            Agile Therapeutics Inc AGRX 10% Owner 2018-07-26 0 2021-10-13 21,654,485    Premium*  
            Verrica Pharmaceuticals Inc. VRCA 10% Owner 2018-06-19 0 2023-12-29 7,099,182    Premium*  
            Athenex, Inc. ATNX 10% Owner 2019-05-06 0 2020-09-14 13,532,467    Premium*  
            ADMA Biologics Inc ADMA 10% Owner 2019-05-21 0 2021-09-30 13,262,375    Premium*  
            Foamix Pharmaceuticals Ltd FOMX 10% Owner 0 2019-07-29 11,203,881    Premium*  
            Lyra Therapeutics, Inc. LYRA Director, 10% Owner 2020-05-05 0 2023-05-31 12,757,563    Premium*  
            VYNE Therapeutics Inc VYNE 10% Owner 2020-06-09 0 2021-08-16 4,935,057    Premium*  
            Leap Therapeutics, Inc. LPTX 10% Owner 2020-06-22 0 2020-06-22 8,476,496    Premium*  
            Athira Pharma, Inc. ATHA Director, 10% Owner 0 2023-12-29 5,402,964    Premium*  
            Cerevel Therapeutics Holdings, I... CERE Director 2020-10-20 0 2024-02-20 10,794,876    Premium*  
            Scynexis Inc SCYX 10% Owner 2021-01-20 0 2021-01-22 1,800,000    Premium*  
            Landos Biopharma, Inc. LABP Director, 10% Owner 0 2021-02-09 17,960,839    Premium*  
            Astria Therapeutics, Inc ATXS Director 0 2024-02-01 6,485,420    Premium*  
            Prometheus Biosciences, Inc. RXDX 10% Owner 2021-03-16 0 2021-03-16 3,314,032    Premium*  
            Rain Therapeutics Inc. RAIN 10% Owner 2021-04-27 0 2021-10-12 2,487,019    Premium*  
            Nautilus Biotechnology, Inc NAUT 10% Owner 2021-05-24 497,038 2021-12-08 9,111,151    Premium*  
            Isoplexis Corp ISO 10% Owner 2021-10-12 0 2021-10-12 3,554,587    Premium*  
            Lianbio LIAN Director, 10% Owner 0 2024-02-15 57,575,533    Premium*  
            Acrivon Therapeutics, Inc. ACRV 10% Owner 0 2024-04-11 5,360,858    Premium*  
            Chembio Diagnostics Inc CEMI Former 10% Owner 2023-04-04 0 2023-04-27 0    Premium*  
            Soleno Therapeutics Inc SLNO 10% Owner 0 2023-06-06 2,207,753    Premium*  
            Cargo Therapeutics, Inc. CRGX Former 10% Owner 2023-11-14 0 2023-11-14 333,333    Premium*  
* Premium Members only  

Records found :    304         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 8 of 13
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ALDX Aldeyra Therapeutics, Inc... 10% Owner   –       –       •   2022-08-10 4 B $7.85 $117,750 I/I 15,000 11,350,085 1.5 %
ALDX Aldeyra Therapeutics, Inc... 10% Owner   –       –       •   2021-01-07 4 B $8.13 $4,065,000 I/I 500,000 6,785,458 1.5 %
SCYX Scynexis Inc 10% Owner   –       –       •   2021-01-22 4 S $8.16 $2,629,781 I/I (319,000) 1,800,000 0 %
ACRV Acrivon Therapeutics, Inc... 10% Owner   –       –       •   2024-04-11 4 B $8.50 $20,000,500 I/I 2,353,000 5,360,858 1.5 %
LYRA Lyra Therapeutics, Inc. Director   –       •       •   2020-05-05 4 OE $8.63 $4,149,520 I/I 480,825 1,471,620 0 -
ALDX Aldeyra Therapeutics, Inc... 10% Owner   –       –       •   2021-01-19 4 B $9.50 $13,000,000 I/I 1,368,421 8,703,879 1.5 %
CERE Cerevel Therapeutics Hold... Director   –       •      –    2020-10-20 4 B $10.00 $1,141,000 I/I 114,100 114,100 2.1 %
CERE Cerevel Therapeutics Hold... Director   –       •      –    2020-10-27 4 B $10.00 $30,000,000 I/I 3,000,000 3,157,295 2.1 %
NAUT Nautilus Biotechnology, I... Former Director   –       –      –    2021-06-09 4 B $10.00 $55,000,000 I/I 5,500,000 5,997,038 0.01 %
NAUT Nautilus Biotechnology, I... Director   –       •      –    2021-05-20 4 B $10.05 $1,607,246 I/I 159,925 159,925 2.1 %
NAUT Nautilus Biotechnology, I... Former Director   –       –      –    2021-05-24 4 B $10.05 $70,983 D/D 7,063 497,038 2.44 %
NAUT Nautilus Biotechnology, I... Director   –       •      –    2021-06-03 4 B $10.05 $3,317,003 I/I 330,050 489,975 2.1 %
CERE Cerevel Therapeutics Hold... Director   –       •      –    2020-10-21 4 B $10.09 $435,838 I/I 43,195 157,295 2.1 %
ATNX Athenex, Inc. 10% Owner   –       –       •   2019-10-16 4 B $10.29 $691,714 I/I 67,222 10,802,467 1.5 -
ATNX Athenex, Inc. 10% Owner   –       –       •   2019-10-17 4 B $10.93 $546,500 I/I 50,000 10,852,467 1.5 -
ATNX Athenex, Inc. 10% Owner   –       –       •   2020-09-14 4 B $11.00 $19,800,000 I/I 1,800,000 13,532,467 1.5 -
ATXS Astria Therapeutics, Inc Director   –       •      –    2022-12-19 4 B $11.01 $9,999,998 I/I 908,265 1,038,309 2.1 %
LABP Landos Biopharma, Inc. Director   –       •       •   2021-02-05 4 B $11.14 $305,826 I/I 27,453 7,077,017 2.25 -
ATNX Athenex, Inc. 10% Owner   –       –       •   2020-09-10 4 B $11.24 $2,248,000 I/I 200,000 11,732,467 1.5 -
LABP Landos Biopharma, Inc. Director   –       •       •   2021-02-08 4 B $11.38 $1,503,061 I/I 123,053 7,200,070 2.25 -
FOLD Amicus Therapeutics Inc 10% Owner   –       –       •   2018-09-13 4 B $11.74 $1,174,000 I/I 100,000 20,624,424 1.5 -
CORI Corium International, Inc... 10% Owner   –       –       •   2018-01-16 4 B $11.83 $595,641 I/I 50,350 5,897,483 1.5 -
FOLD Amicus Therapeutics Inc 10% Owner   –       –       •   2018-09-12 4 B $12.00 $6,001,500 I/I 500,000 20,524,424 1.5 -
RAIN Rain Therapeutics Inc. 10% Owner   –       –       •   2021-10-11 4 S $12.03 $273,040 I/I (21,826) 2,494,325 0 -
ATNX Athenex, Inc. 10% Owner   –       –       •   2019-05-06 4 B $12.08 $1,271,148 I/I 100,000 9,196,022 1.5 -
  304  Records found
  1   2   3   4   5   6   7   8  9   10   11   12   13      
  Page 8 of 13  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us